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Abstract 
Background: One of the most common difficu lties found in leprosy management 
is how to manage leprosy reaction, even though MDT has proven to be effective 
for the patients. Reversal reaction is associated with cell mediated immunity 
(CMI), consists of T-helper (Th) 1 and Th2 act ivit ies. Moreover, subset of CD4+ 
Th17 and CD25+ FOXP3 Treg were known to have an important role in leprosy’s 
natural history. Prior study showed a decreasing number of CD25+ FOXP3 Treg  
and increasing number of CD4+ Th17 in type II reversal reaction (ENL). However, 
the distribution of Th17 and Treg in type I reversal reaction (RR) has not yet been 
identified. 
Objective: To compare the distribution of CD4+ Th17 and CD25+ FOXP3 Treg  
between RR and ENL patient groups. 
Method: A total of 50 samples, consisted of 27 samples of reversal reaction (RR) 
and 23 samples of ENL, were collected. Observation of CD4+ RORg-T Th17 and 
CD25+ FOXP3 Treg were conducted with immunohistochemistry staining 
technique using anti FOX-P3 and anti RORg-T. Expression of CD4+ ROR-g Th17 
and CD25+ FOXP3 Treg in percentage were analyzed using T-test. 
Result: There is a significant difference in mean CD4+ ROR-g Th17 and IL17 cell 
distribution for RR patient group (14.96% and 10.72%) compared with ENL 
(9.12% and 4.28%). No significant difference were found between mean CD25+ 
FOXP3 Treg and TGF-β cell distribution in RR patient group (6.12% and 5.44%) 
compared with ENL group (6.16% and 5.96%).  
Conclusion: There is a significant increment od CD+RORg-T Th17 and IL17 in  
RR patients group compared with ENL patients group. however, the distribution of 
CD25+ FOXP3+ Treg and TGF beta in RR has no significant difference campared  
with ENL. 
 
Keywords: CD4+RORg-T Th17, CD25+ FOXP3+ Treg, IL17, TGF-β, Reversal 
Reaction, Erythema Nodosum Leprosum 
INTRODUCTION 
Leprosy is a frightening disease for community 
which cause ulceration, mutilation, and deformit ies to 
the patients. The disease has variety of manifestations 
depend on patient’s immune response towards the 
infection. Two key purposes from leprosy 
management are recovery and disability prevention 
from the disease. WHO recommended a Multi Drug  
 
Therapy (MDT) consists of rifampicin and dapsone 
for PB leprosy, and rifampicin, dapsone, and 
clofazimine to treat MB leprosy. Therapy is given for 
6 months duration for PB leprosy and 12 months 
duration for MB leprosy. MDT has been proven 
effective to eradicate M. leprae in most of the 
patients.
1
 Even though it has been proven effective,  
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the most difficult issue in leprosy management is to 
manage the leprosy reaction. 
 Leprosy reaction is caused by patient’s 
immunological dynamic response to M. leprae which 
could happen before, during, and after MDT 
administration.
2
This reaction is an acute episode of 
the disease with constitutional symptoms, activation, 
sometimes accompanied with new skin efflorescence. 
Two types of leprosy reaction are type 1, known as 
reversal reaction (RR), caused by acute changes in 
cellu lar immunity, and type 2 reaction known as 
eritema nodosum leprosum (ENL), caused by humoral 
immunity process.
3
 Reversal reaction is associated 
with cell mediated immunity (CMI) activit ies, 
consists of T-helper cell (Th1) and (Th2). It is 
characterized with granuloma expansion, edema, 
CD4+ recru itment, increasing IL-2, IL-10, and IL-12 
receptors, and expression of human leukocyte 
antigens-D in cellular infiltrate.
4
 
 Another CD4+ Th subset that shows divergence in 
leprosy is the Th17 populationassociated with 
inflammat ion.
5
 The Th17 subset is highest in healthy 
contacts exposed to the diseases compared with 
patients, indicating its importance in innate 
immunity.
6,7
 Th17 cells appeared in the leprosy 
patients who showed non-polarised Th0 subset.
6
 
Therefore it would appear that Th17 plays a ro le in 
the immune responses to M. leprae infection and may 
be an alternate pathway for bacillary clearance both in 
the early and later stages of infection. The associated 
chemokines may help in its migrat ion to lesional sites.  
 Another distinct lineage of T cells that has 
excit ing implications for dampening inflammatory 
responses is the T regulatory cell (Treg), which has a 
CD4+CD25+ nuclear FOXP3+ phenotype and shares 
a similar d ifferentiation pathway to Th17 cells, 
although they have opposite effects.Several types of 
Tregs have been described; some are natural Tregs 
derived from the thymus and act via contact with 
target cells.
8
 Others are inducible and mediate 
inhibit ion through cytokines such as transforming 
growth factor-β (TGF-β) and IL-10 (induced Treg 
[iTreg]).
9
 Transcription factor FOXP3 is thought to be 
the primary requirement for the suppressive function, 
though low and transient expression has been reported 
in activated human T cells with and without 
suppressor function. Though Tregs in mice express 
CD25 constitutively, in  humans only those with CD25 
show suppressive function.
10
 
 Leprosy reactions in contrast showed a decrease in 
Treg cells which paralleled the increase in Th17 
population.
11
 Moreover, there was downregulation of 
intracellular TGF-β.11,12Most reports showed a 
reduction in Treg cells in patients with ENL reactions 
compared with non-reaction L-lep counterparts. Akan 
tetapi pada reaksi kusta tipe I (RR) bagaimana 
distribusi Th17 dan Treg masih belum 
jelas.
11,12
However, in type I leprosy reaction (RR), the 
distribution of Th17 and Treg has not yet been 
identified. Thus, this study aimed to compare the 
distribution between Th17 and FOXP3 Treg in RR 
and ENL patient groups. 
 
METHOD 
A total of 50 samples were used in this study, 
consisted of 27 samples of RR patients and 23 
samples of ENL patients. The samples were collected 
from outpatient clin ic in Donorojo Hospital and 
Ministry of Health in Jepara from June 2014-August 
2014. Patients were 20-60 years old and had agreed to 
sign the standard informed consent from Ethical 
Committee of Airlangga University. 
Biopsy samples were collected at the lesion area 
or lower arm extensor side. Then, the area was 
disinfected with alcohol 70% and local anesthetic 
Lidocaine 0.25 ml was administered subcutaneously 
near the biopsy area. Biopsy were conducted using 
punch method with diameter of 3 mm. Tissue sample 
was inserted to a 1.5 ml tube filled with formalin 
10%. The after-biopsy skin was cleaned using NaCl 
0.9%, then topical antibiotic fusidic acid was applied 
and the skin was covered with sterile gauze. The 
sample underwent a fixation and processed in 
paraffin. Microscopic slide was made using rotary 
microtome with 4µm slicing. Stain ing with 
Hematoxylin-Eosin was applied to confirm the 
structure and leprosy type. Observation of CD4+ 
RORg-T Th17 and C25+ FOXP3+ Treg were using 
immunohistochemistry single staining technique with 
anti-FOX-P3 anti RORg-T retrieved from Santa Cruz 
Biotech (USA) and immunohistochemistry kit  of D-
Bio Sys Immunostaining Kit (Netherland). The 
staining result was then photomicrographed using 
Niokon E-100 Microscope with ICLEA7 Sony 
Camera 400x magnification, then expression analysis 
was done using immunoratio software (Freeware). 
Percentage of expression CD4+ RORg-T Th17 and 
C25+ FOXP3+ Treg were inserted to table and 
analyzed using T-test in IBM-SPSS 21 for W indows. 
 
RES ULT 
In this study, there were 27 samples of RR patients 
and 23 patients of ENL patiens. Each cases were 
classified based Hematoxylin-Eosin (HE) staining 
microscope examination, as the figure below.  
 
 
Figure 1. ENL: Granulomatous infiltrate of 
vacuolated macrophages and neutrophils in the 
dermis. RR: Influxof mononuclear phagocytes with 
epithelioid differentiat ion. Hematoxylin– eosin 
staining; original magnification x200 and x1000 
inserted. 
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 Expression of FOXP3, RORg -T, TGFb1 and 
IL-17 are described below: 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Immunohistochemistry staining for Foxp3, 
RORgT, TGFb1 and IL17A from biopsy samples of 
RR and ENL patients. Photomicrograph showing 
(Orig inal magnification:400×) RORgT and FOXp3 
cells positive in brown co lor (arrow).  
Immunohistochemistry study result showed a 
significant difference in mean CD4+RORg-T Th17 
and  IL17 cell distribution in RR patient group 
(14.96% and 10.72%) compared with ENL patient 
group (9.12% and 4.28%). However, no significant 
difference in mean CD25+ FOXP3+ Treg and TGF-β 
cell d istribution in RR patient group (6.12% and 
5.44%) compared with ENL patient group (6.16% and 
5.96%). 
 
Graphic 1. Mean FOXP3, RORgT, TNFα dan IL17 
percentage in RR and ENL patient group. We found a 
significant difference in CD4+RORgT Th17 and IL17 
in RR patient group (14.96% and 10.72%) compared 
with ENL patient group (9.12% and 4.28%).  
 
DISCUSS ION 
In this study, exp ression of FOXP3+ was 
evaluated from the skin with T lymphocyte infiltrate. 
We found that Treg cells were produced in reactive 
state (either type I or II). Treg cell has an important 
role in controlling the overactive immune response 
towards microbe’s antigen, especially pathogens 
which caused persistent infection in this study. Prior 
study has explained a significant decrement of 
FOXP3+ Treg in ENL compared with stabilized 
leprosy patients, although it was not found in RR 
patients.
12
In this study, we found FOXP3+ Treg in all 
skin specimens of RR and ENL with a low number. 
From all of the case, positive FOXP3 cell was 
strongly related with epithelio id or macrophage, 
showing a functional interaction between Treg and 
histiocyte. We observed no statistically significant 
differences between FoxP3+ Treg cells between type I 
reaction (RR) and type II reaction (ENL), even the 
number is almost the same. 
Other study showed that CD+ FOXP3+ T-Reg cell 
produced TGF-β and increased in stabilized 
lepromatous patients and also could explain issues 
with this type of leprosy.
11
our study showed that 
TGFb1 occurred in type I leprosy reaction (RR) and 
type II (ENL), where the presentation tends to be 
lower in RR thatn ENL, but this is not statistically 
significant. 
This study emphasized an inhibition of FOXP3 
cell expression and also TGF-β in  RR condition 
compared with ENL, which related to an 
unresponsiveness of T cell observed in RR patients. 
One interesting finding in this study is an increasing 
RORgT Th17 positive cells found in RR leprosy 
compared with ENL patients, and it was statistically 
significant. Also, RR patients showed a higher IL-
17A expression than ENL patients. 
The present study was undertaken with a view to 
understanding the inflammation and or 
immunopathology seen in patients under going 
episodes of leprosy reactions which are a cause of 
severe morbidity and nerve damage. Previous studies 
had shown that Th17 cells formed a third subset in 
leprosy and were seen in stable leprosy patients in the 
absence of Th1 and Th2 polarization.
11
Our study 
showed a disturbed equilibrium between Th17 cells 
and Treg cells in leprosy reaction, especially 
increased Th17 cells and decreased Treg cells in 
number. Th is imbalance was mediated by cytokines, 
showed by decreasing TGF-β number in the same 
time. Increasing Th17 activ ities with IL-17A 
expression would explain the inflammatory and 
immunopathology process caused by leprosy reaction. 
Overall, our results provide some evidence to the 
hypothesis that, in T1R, downmodulation of Tregs 
cells would favor the development of Th-17 responses 
that characterize this type of reaction. We thus believe 
that better understanding of the role played by Tregs 
cells in reaction episodes can possibly provide a new 
target for the treatment of this still-challenging 
complication of leprosy. 
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